Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rog

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Discovery|June 1, 2012
A drug discovery case history of 'delta-9-tetrahydrocannabinol, cannabidiol'Radu Tanasescu, David Rog, Cris S Constantinescu
Patient Preference and Adherence|February 27, 2014
Patient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practiceMehmood Syed, David Rog, Laura Parkes, et al.
BMJ Case Reports|June 17, 2017
Fingolimod-associated macular oedemaKirti Madhukar Jasani, Nazar Sharaf, David Rog, et al.
Practical Neurology|January 20, 2012
The unfolding tale of an unusual brain stem syndromeSuresh Kumar Chhetri, Rekha Siripurapu, David Rog, et al.
Practical Neurology|January 20, 2025
Assisted reproduction technology in multiple sclerosisGer Mullan, Stella Hughes, David Rog, et al.
Multiple Sclerosis and Related Disorders|December 24, 2021
"I'm walking into the unknown": Qualitative insights into how emotions and lived experience related to multiple sclerosis diagnosis impact on decisions to pursue disease modifying treatmentGina Carey, Neil Wilson, Jessie Janssen, et al.
Journal of the Neurological Sciences|March 13, 2026
Fatigue prevalence, interactions with associated symptoms and longitudinal changes in those with multiple sclerosis: Insights from the TONiC studyCarolyn A Young, David Rog, Radu Tanasescu, et al.
Multiple Sclerosis and Related Disorders|December 1, 2018
Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview studyElaine Cameron, David Rog, Gavin McDonnell, et al.
Multiple Sclerosis and Related Disorders|June 17, 2017
Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosisKeh Yann, Fran Jackson, Nazar Sharaf, et al.
Multiple Sclerosis and Related Disorders|January 15, 2019
Inequalities in access to health and social care among adults with multiple sclerosis: A scoping review of the literatureHazel Roddam, David Rog, Jessie Janssen, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Discovery|June 1, 2012
A drug discovery case history of 'delta-9-tetrahydrocannabinol, cannabidiol'Radu Tanasescu, David Rog, Cris S Constantinescu
Patient Preference and Adherence|February 27, 2014
Patient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practiceMehmood Syed, David Rog, Laura Parkes, et al.
BMJ Case Reports|June 17, 2017
Fingolimod-associated macular oedemaKirti Madhukar Jasani, Nazar Sharaf, David Rog, et al.
Practical Neurology|January 20, 2012
The unfolding tale of an unusual brain stem syndromeSuresh Kumar Chhetri, Rekha Siripurapu, David Rog, et al.
Practical Neurology|January 20, 2025
Assisted reproduction technology in multiple sclerosisGer Mullan, Stella Hughes, David Rog, et al.
Multiple Sclerosis and Related Disorders|December 24, 2021
"I'm walking into the unknown": Qualitative insights into how emotions and lived experience related to multiple sclerosis diagnosis impact on decisions to pursue disease modifying treatmentGina Carey, Neil Wilson, Jessie Janssen, et al.
Journal of the Neurological Sciences|March 13, 2026
Fatigue prevalence, interactions with associated symptoms and longitudinal changes in those with multiple sclerosis: Insights from the TONiC studyCarolyn A Young, David Rog, Radu Tanasescu, et al.
Multiple Sclerosis and Related Disorders|December 1, 2018
Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview studyElaine Cameron, David Rog, Gavin McDonnell, et al.
Multiple Sclerosis and Related Disorders|June 17, 2017
Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosisKeh Yann, Fran Jackson, Nazar Sharaf, et al.
Multiple Sclerosis and Related Disorders|January 15, 2019
Inequalities in access to health and social care among adults with multiple sclerosis: A scoping review of the literatureHazel Roddam, David Rog, Jessie Janssen, et al.
Pageof 5